The Oklahoma Medical Marijuana Authority has issued three product recalls this month involving thousands of products as it steps up lab testing enforcement. Meanwhile, Greenleaf Labs has resumed operations after its license suspension was lifted.
The latest recalls, involving Green Delight, Ruby Mae’s and Rocking R Cannabis, follow the suspension of Greenleaf Lab’s license and the changing of 19,000 products from pass to fail in August.
Chris Dooly, Greenleaf Labs co-owner and managing member, told CRB Monitor News that a missed email two years ago led OMMA to issue a warning on the flower products, which were never embargoed. He said it was an oversight that may have led to mold in products. After working with OMMA and strengthening its internal procedures, the lab passed inspections Sept. 25 and restarted operations.
“Overall, it made us so much better. Everyone is so much more knowledgeable.” he said. “We’re trying to protect ourselves from anything like this happening again.”
As a result of this experience, Dooly said OMMA inspectors told him they would inspect all the labs to “get everyone on the same level.”
OMMA officials did not respond to a question about that comment. But the agency has since issued two enormous recalls of thousands of products going back three years for “improper testing methods.” A third recall on Oct. 24 was for pesticides.
Ruby Mae’s, Rocking R Cannabis, Green Delight products recalled
More than 3,000 products produced Ruby Mae’s were recalled Oct. 23. The pre-roll and vape products date back to July 5, 2022. The most recent products were made Oct. 17, 2025. An embargo was issued Oct. 13.
Travis Hunter, senior manager of Bixby-based Ruby Mae’s, said the recall was not related to Greenleaf Labs or a failed test. He otherwise declined to comment while they work through the recall.
On Oct. 10, OMMA issued a recall of 286 products manufactured by Michael William Redus, d.b.a. as Rocking R Cannabis. The recall includes pre-roll products packaged as early as Oct. 10, 2022, and as recent as Sept. 17, 2025. An embargo was issued Sept. 25. Pre-rolls packaged this year were sold at about a dozen different dispensaries.
Dooly said Greenleaf did not test Rocking R Cannabis products.
Representatives for Rocking R Cannabis did not respond to emails listed in the CRB Monitor database requesting comment. OMMA didn’t respond to questions asking for more details about the testing problems that led to the recalls.
Additionally, OMMA recalled Cherry Cosmo flowers sold by Green Delight 2, LLC, a dispensary in Oklahoma City, after failing for unspecified pesticides.
Greenleaf pays for retesting
Following a routine inspection in late July, Greenleaf Labs in Poteau had its license suspended because it hadn’t been following a vendor’s standard operating procedures (SOP) for testing equipment.
Dooly said Greenleaf is an accredited cannabis testing lab and has been licensed since 2021. He formed the company with Dr. Randy Matos, both of whom had lab-testing backgrounds. At its peak, the company was testing for at least 500 growers.
Greenleaf’s problems began when vendor Medicinal Genomics, a lab equipment company, sent an email in April 2023 about changed testing methods for yeast and mold. In July 2025, a microbiologist from Medicinal Genomics visited Greenleaf and noticed Greenleaf was still using the old testing method.
“I don’t know why it didn’t get implemented at the time,” Dooly said. The lab director no longer works with the company and won’t respond to his questions.
Dooly said the state regulations require labs to follow a vendor’s SOPs. Testing methods were changed that day, which was a Wednesday. The next Monday, OMMA inspectors visited. OMMA had said it was a routine inspection.
But the problem of what to do with the products was complex, with many items likely no longer in circulation.
“It was a mess. They didn’t know how to handle it,” Dooly said of OMMA.
On the night of Aug. 12, OMMA changed the status of 19,000 samples tested by Greenleaf from passed to failed and notified retailers. But an official embargo or recall was never issued.
In the meantime, Dooly worked closely with OMMA to strengthen internal systems, implement enhanced compliance protocols, streamline processes and expand staff training. For example, he said they put protocols in place so that vendor emails are sent to more than one person.
He said the specific issue was mold, which not all states even test for. Oklahoma’s limit is 10,000 colony forming units. But if there’s any amount of mold in the product, it can grow while sitting on the shelf. Greenleaf now uses a new method that detects any amount of mold.
They also paid for their clients to retest products and decontaminate them if they failed. He said some of the retested products failed but “a lot” passed.
“I chose the higher road,” Dooly said. “It was an expensive lesson.”
Dooly said they “went through the ringer” with OMMA. “It affected a lot of lives,” as he had 21 employees at the time. But in the end, OMMA “told us we’ll be the gold standard of testing.”
He said Greenleaf’s license was reinstated in August, and they started running tests Sept. 26 after passing the state inspection. The company was not fined, he said.
He added that Medicinal Genomics “went to bat” for them, and they had a lot of support. They are starting to get some clients back.
“Our mission remains the same: to provide reliable, high-quality cannabis testing services that protect patients, support our clients, and uphold the integrity of the industry,” said a company statement.
“We’re deeply grateful for the trust, patience, and support shown by our clients and community during this period. We’re excited to move forward — stronger, smarter, and more committed than ever to excellence in compliance testing.”
